Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and CSF
<p>Biomarkers to aid diagnosis and delineate progression of Parkinson’s Disease are vital for targeting treatment in the early phases of disease. Here, we aim to discover a multi-protein panel representative of Parkinson’s and make mechanistic inferences from protein expression profiles within...
Main Authors: | Winchester, L, Barber, I, Lawton, M, Ash, J, Liu, B, Evetts, S, Hopkins-Jones, L, Lewis, S, Bresener, C, Malpartida, AB, Williams, N, Gentlemen, S, Wade-Martins, R, Ryan, B, Nevado-Holgado, A, Hu, M, Ben-Shlomo, Y, Grosset, D, Lovestone, S |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Oxford University Press
2022
|
Registos relacionados
-
The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
Por: Westwood, S, et al.
Publicado em: (2017) -
Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease
Por: Winchester, L, et al.
Publicado em: (2018) -
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
Por: Delvenne, A, et al.
Publicado em: (2024) -
Mitochondrial dysfunction and mitophagy in Parkinson’s disease: From mechanism to therapy
Por: Malpartida, AB, et al.
Publicado em: (2020) -
Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer's disease: A bioinformatics approach
Por: Nevado-Holgado, A, et al.
Publicado em: (2016)